NASDAQ: NRSN
Neurosense Therapeutics Ltd Stock Ownership - Who owns Neurosense Therapeutics?

Insider buying vs selling

Have Neurosense Therapeutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NRSN insiders and whales buy or sell their stock.

NRSN Shareholders

What type of owners hold Neurosense Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Squarepoint Ops LLC0.39%95,375$83.45kInstitution
Morgan Stanley0.27%66,400$58.10kInstitution
Meitav Investment House Ltd 10.16%40,000$35.00kInstitution
Two Sigma Investments LP0.09%21,086$18.45kInstitution
Commonwealth Equity Services LLC0.09%21,080$18.45kInstitution
Geode Capital Management LLC0.06%15,870$13.89kInstitution
Ubs Group Ag0.06%14,659$12.83kInstitution
Sbi Securities Co Ltd0.01%1,455$1.27kInstitution
Jones Financial Companies LLLP0.00%1,000$875.00Institution
Cwm LLC0.00%1,000$875.00Institution

1 of 1

NRSN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRSN1.13%0.00%
CLGN13.19%0.00%
QCLS0.23%99.77%
NEUP2.77%97.23%Net BuyingNet Buying
CVKD5.50%53.59%Net SellingNet Selling

Neurosense Therapeutics Stock Ownership FAQ

Who owns Neurosense Therapeutics?

Neurosense Therapeutics (NASDAQ: NRSN) is owned by 1.13% institutional shareholders, 0.00% Neurosense Therapeutics insiders, and 98.87% retail investors. Squarepoint Ops LLC is the largest individual Neurosense Therapeutics shareholder, owning 95,375.00 shares representing 0.39% of the company. Squarepoint Ops LLC's Neurosense Therapeutics shares are currently valued at $84.88k.

If you're new to stock investing, here's how to buy Neurosense Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.